{"id":"NCT00118417","sponsor":"Massachusetts General Hospital","briefTitle":"Therapies for Treatment-Resistant Panic Disorder Symptoms","officialTitle":"Treatment Refractory Panic Disorder","status":"COMPLETED","phase":"PHASE2","dates":{"start":"1999-03","primaryCompletion":"2007-10","completion":"2007-10","firstPosted":"2005-07-11","resultsPosted":"2009-07-28","lastUpdate":"2014-06-11"},"enrollment":46,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Panic Disorder"],"interventions":[{"type":"DRUG","name":"Clonazepam","otherNames":[]},{"type":"DRUG","name":"Sertraline","otherNames":[]},{"type":"BEHAVIORAL","name":"Cognitive behavioral therapy","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"EXPERIMENTAL"}],"summary":"This study will determine the effectiveness of different treatments for panic disorder symptoms in individuals who still have symptoms after initial treatment with medication.","primaryOutcome":{"measure":"Change in Panic Disorder Symptoms, Phase 1 (Week 0 - Week 6)","timeFrame":"Measured at baseline and after Phase 1 (6 weeks)","effectByArm":[{"arm":"Moderate Sertraline Treatment","deltaMin":4.3,"sd":4.3}],"pValues":[{"comp":"OG000","p":"0.0000"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":4},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["19814948"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":39},"commonTop":["Gastrointestinal distress","Headache","Jitteriness or Restlesness","Nausea or Vomiting","Insomnia"]}}